Over the past decades, SPOP has been confirmed as a tumour suppressor in several cancers, including prostate cancer, lung cancer and gastric cancer, and studies of the differential expression levels and mutation status of SPOP have indicated that SPOP plays different roles in cancer cell development [16]. The gene discussed is SPOP; the disease is prostate carcinoma.